AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 38199593
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy
Trial: 35441218
Drug: Daily rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily rice bran supplementation (1 to 5 g/d)
Trial: 36858762
Drug: Text-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text-delivered cognitive behavioral therapy (CBT-txt)
Trial: 33539744
Drug: Carboplatin-based doublet
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin-based doublet plus bevacizumab (10 mg/kg intravenous every 14 days or 15 mg/kg every 21 days)
Trial: 34323455
Drug: Transforaminal Epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal Epidural Steroid Injection (TFESI)
Trial: 35766954
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine infusion (ILI) 1.5 mg/kg as a bolus followed by 1.5 mg/kg/h until the end of surgery (Group L)
Trial: 34155070
Drug: Guided daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided daily multidisciplinary rounds (DMRs) supported by a remote specialist and audit/feedback on care performance
Trial: 35712635
Drug: Partially hydrolyzed
RxNorm normalized name: Human Skin Proteins, Partially Hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrolyzed cow’s milk protein formula (PHF, 75% carbohydrate as lactose; 12 mg Mg/100 kcal)
Trial: 32384437
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (CSI) - a single 1-mL dose of betamethasone sodium plus 0.5 mL of prilocaine under ultrasound guidance (n=40)
Trial: 39248249
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus aspirin
Trial: 36326260
Drug: Abdomen infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abdomen infusion site
Trial: 34657218
Drug: Dapivirine gel
RxNorm normalized name: dapivirine
DrugBank: Dapivirine (DB08639)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapivirine gel
Trial: 34994269
Drug: Triple Pill
RxNorm normalized name: Triple Wormer Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple Pill
Trial: 34387964
Drug: Ibuprofen (IBU)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (IBU)
Trial: 32561160
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (iGlar)
Trial: 35138767
Drug: Endovascular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular therapy with medical care
Trial: 33750471
Drug: Biologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologic therapy targeting Type 2 inflammatory pathway (e.g., IL-4, IL-5, IL-13, IL-5R, IL-33, IgE)
Trial: 35589771
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (CPT, n=10)
Trial: 32311780
Drug: Pegfilgrastim (PEG)
RxNorm normalized name: Pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pegfilgrastim (PEG) 6 mg
Trial: 35939559
Drug: ESO 20
RxNorm normalized name: NY-ESO TCR therapeutic
DrugBank: Letetresgene autoleucel (DB17233)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESO 20 mg plus AMX 750 mg, Qid for 14 days (Group A)
Trial: 32575945
Drug: Targeted artery
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted artery perfusion of verapamil and chemotherapy drugs
Trial: 32575945
Drug: Targeted artery
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted artery perfusion of chemotherapy drugs alone (Control)
Trial: 35311446
Drug: Multi-fiber bread
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-fiber bread (150 g daily, enriched with a 7-dietary fiber mixture providing 16.05 g of fibers)
Trial: 39137016
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control
Trial: 33359589
Drug: PTAH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTAH treatment beyond 1 year
Trial: 35380374
Drug: ON-SXB 9
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ON-SXB 9 g
Trial: 32320024
Drug: Moderate-dose fiber
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose fiber (7 g/d)
Trial: 34882076
Drug: Indapamide retard
RxNorm normalized name: Indapamide
DrugBank: Indapamide (DB00808)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indapamide retard 1.5 mg and valsartan 160 mg in the morning (Group 1)
Trial: 32072735
Drug: Glimepiride plus
RxNorm normalized name: Glimepiride
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glimepiride plus metformin
Trial: 32462483
Drug: Minimally invasive
RxNorm normalized name: SPY Minimally Invasive Surgery (SPY-MIS) Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimally invasive surfactant therapy (MIST)
Trial: 34003586
Drug: Antipsychotic drugs
RxNorm normalized name: Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic drugs
Trial: 39637881
Drug: Filgotinib 200
RxNorm normalized name: nilotinib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgotinib 200 mg
Trial: 33693813
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplements
Trial: 39247962
Drug: Cognitive-Behavioral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-Behavioral Therapy (CBT)
Trial: 36512175
Drug: Abrocitinib 200
RxNorm normalized name: abrocitinib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrocitinib 200 mg once daily
Trial: 34493431
Drug: TAS-115 200
RxNorm normalized name: Ta
DrugBank: Tantalum (DB12859)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAS-115 200 mg/d
Trial: 34430972
Drug: Rivaroxaban 2.5
RxNorm normalized name: rivaroxaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 2.5 mg twice/day plus aspirin 100 mg/day
Trial: 33350678
Drug: Single-agent second-line
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent second-line therapy
Trial: 35426830
Drug: Bevacizumab 2.5
RxNorm normalized name: Bevacizumab 2.5 MG/0.1 ML Intraocular Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 2.5 mg/kg administered as a one-time targeted intra-arterial infusion after blood-brain barrier disruption (BBBD)
Trial: 33186325
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg per day
Trial: 36401445
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (sodium lactate Ringer's solution)
Trial: 32220910
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate
Trial: 32037254
Drug: High Lp(a)
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Lp(a) group (Lp(a) >20 mg/dl)
Trial: 32568196
Drug: Crenezumab 120
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Crenezumab 120 mg/kg intravenously every 4 weeks for 13 weeks
Trial: 32568196
Drug: Crenezumab during
RxNorm normalized name: Fremanezumab
DrugBank: Fremanezumab (DB14041)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Crenezumab during open-label extension (OLE) at originally assigned dose level, except for Cohort 3 (crenezumab 60 mg/kg during OLE)
Trial: 34968756
Drug: Aflibercept 2
RxNorm normalized name: ziv-aflibercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflibercept 2 mg
Trial: 33332813
Drug: Systemic medications
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic medications (including cholinesterase inhibitor, ACE inhibitors, calcium channel blockers, beta‐blockers, diuretics, aspirin, steroids, statins, hormone replacement therapy, antacids, and drugs targeting G protein‐coupled receptors)
Trial: 32319465
Drug: Juice enriched
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juice enriched with highly polymerized inulin (12 g per 300 mL)
Trial: 33707267
Drug: Pleuran oral
RxNorm normalized name: PLEURAL DRAINAGE KIT ROCKET #51411
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pleuran oral suspension
Trial: 32062048
Drug: 6 weeks
RxNorm normalized name: perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 6 weeks of twice-weekly rifapentine plus isoniazid (group B)
Trial: 32033579
Drug: Gradual dose
RxNorm normalized name: MEDICINE DOSE CUP GRADUATED 30ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gradual dose reduction till eventual discontinuation of antipsychotics according to a tapering schedule
Trial: 32873290
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg/day for 3 days
Trial: 34225517
Drug: MDT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDT treatment
Trial: 35238614
Drug: Phlebotomy group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebotomy group (500 mL bloodletting at baseline and after 6 weeks)
Trial: 33934070
Drug: Tocilizumab monotherapy
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab monotherapy (TCZm)
Trial: 33982141
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (OT) 24 IU twice daily for 4 weeks
Trial: 34897499
Drug: Abatacept +
RxNorm normalized name: Abatacept
DrugBank: Abatacept (DB01281)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Abatacept + MTX >8 mg/week
Trial: 33384827
Drug: Fixed oral
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed oral appliance (OA)
Trial: 32247714
Drug: Intermittent enteral
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent enteral feeding (six 4-hourly feeds per 24 h, n = 62)
Trial: 34383534
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose methylphenidate (0.6 mg/kg/dose)
Trial: 36038001
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of a balanced mixture of amino acids (2 g/kg ideal body weight/day)
Trial: 36038001
Drug: Placebo (balanced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (balanced crystalloid solution)
Trial: 35553047
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg
Trial: 37928925
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (control group).
Trial: 37722559
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy (MT)
Trial: 36056362
Drug: EMDR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR therapy (4 sessions of 90 minutes each, divided over two half-days)
Trial: 38061553
Drug: EMDR therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMDR therapy
Trial: 36097258
Drug: Oral ivermectin
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ivermectin
Trial: 33590471
Drug: Oxcarbazepine (OXC)
RxNorm normalized name: Oxcarbazepine
DrugBank: Oxcarbazepine (DB00776)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (OXC) monotherapy
Trial: 32943115
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine (0.1 ml of resuspended BCG vaccine administered intradermally)
Trial: 32502940
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NaCT)
Trial: 36638112
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg/day
Trial: 38715179
Drug: Dulaglutide 0.75
RxNorm normalized name: DULAGLUTIDE 0.75MG/0.5ML INJ PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 0.75 mg
Trial: 32801202
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg elemental iron as ferrous sulfate
Trial: 38735015
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH)
Trial: 32112555
Drug: Music Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music Therapy (MT) combined with Skin-to-Skin Care (SSC)
Trial: 39747681
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg
Trial: 616877161
Drug: VPA +
RxNorm normalized name: VPA
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VPA + memantine (5 mg/day)
Trial: 34326035
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment for NMZL
Trial: 34528669
Drug: Intensive Treatment
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive Treatment Group (targeted SBP <120 mm Hg)
Trial: 33742207
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (100,000 IU monthly)
Trial: 36507215
Drug: Riluzole administration
RxNorm normalized name: Riluzole
DrugBank: Riluzole (DB00740)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riluzole administration (group A)
Trial: 35943883
Drug: Riboflavin 100
RxNorm normalized name: riboflavin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riboflavin 100 mg/d
Trial: 35943883
Drug: Combined Riboflavin
RxNorm normalized name: Riboflavin
DrugBank: Riboflavin (DB00140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined Riboflavin 50 and 100 mg/d
Trial: 36227672
Drug: Oral montmorillonite
RxNorm normalized name: Montmorillonite
DrugBank: Montmorillonite (DB13654)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral montmorillonite powder
Trial: 33711179
Drug: Nemolizumab 30
RxNorm normalized name: Nemolizumab 30 mg in 100 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NEMLUVIO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nemolizumab 30 mg
Trial: 33612360
Drug: Ferric derisomaltose
RxNorm normalized name: ferric derisomaltose
DrugBank: Ferric derisomaltose (DB15617)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferric derisomaltose 20 mg/kg
Trial: 35034502
Drug: Second novel
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second novel hormone therapy (NHT)
Trial: 32951715
Drug: Melatonin 6
RxNorm normalized name: melatonin 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 6 mg daily, 1 hour before bedtime for 12 weeks
Trial: 35120408
Drug: Restorative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restorative treatment (RT)
Trial: 32049319
Drug: Dose Reduction
RxNorm normalized name: Rebetron Combination Package for Rebetol Dose Reduction, Intron A 6,000,000 UNT/ML Multi-Dose Vial / 42 Rebetol Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose Reduction (DR)
Trial: 32271718
Drug: Exebacase +
RxNorm normalized name: Exebacase
DrugBank: Exebacase (DB16161)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exebacase + antibiotics (MRSA patients)
Trial: 34120773
Drug: Dasatinib 100
RxNorm normalized name: dasatinib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib 100 mg once daily
Trial: 35148753
Drug: Previous psychological
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Previous psychological treatment for PMDD
Trial: 36384181
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) in seven weekly sessions for eight weeks
Trial: 36123649
Drug: Home Treatment
RxNorm normalized name: Home-brew
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home Treatment with Peer Support (HT + PS)
Trial: 32807158
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of multi-acupoints
Trial: 34389292
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no aspirin).
Trial: 33985457
Drug: Surgical glove
RxNorm normalized name: Astrapro Surgical Gloves
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical glove compression therapy (two one-size-smaller gloves on one hand)
Trial: 36050514
Drug: BNT162b2 vaccine
RxNorm normalized name: SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 Injectable Suspension [Comirnaty]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNT162b2 vaccine in SARDs patients
Trial: 36050514
Drug: BNT162b2 vaccine
RxNorm normalized name: SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 Injectable Suspension [Comirnaty]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNT162b2 vaccine in control group
Trial: 35771533
Drug: Long-term oxygen
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oxygen therapy
Trial: 34702183
Drug: Erector Spinae
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erector Spinae Plane block (ESPB) with 40 ml of 0.5% Ropivacaine, divided into two equal volumes, injected at T8 level under ultrasound guidance.
Trial: 36593070
Drug: Ibrutinib monotherapy
RxNorm normalized name: Ibrutinib
DrugBank: Ibrutinib (DB09053)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ibrutinib monotherapy
Trial: 32084218
Drug: Tyrosine administration
RxNorm normalized name: Tyrosine
DrugBank: Tyrosine (DB00135)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tyrosine administration
Trial: 34910312
Drug: Odiparcil 500
RxNorm normalized name: Odiparcil
DrugBank: Odiparcil (DB06609)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odiparcil 500 mg twice daily
Trial: 33285343
Drug: Intravenous meglumine
RxNorm normalized name: Meglumine
DrugBank: Meglumine (DB09415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous meglumine antimoniate (IV‐MA) administered via intravenous injections at a dosage of 10–20 mg Sb5+/kg/day for 20 days.
Trial: 39461860
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy
Trial: 34969608
Drug: Mebeverine capsule
RxNorm normalized name: mebeverine
DrugBank: Mebeverine (DB12554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebeverine capsule
Trial: 34032758
Drug: Patient Engagement
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient Engagement and Medication Safety Management (PE‐MSM) program
Trial: 32342893
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 165° backrest angle with a seat pan of 20°
Trial: 34352069
Drug: filgotinib 200
RxNorm normalized name: nilotinib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: filgotinib 200 mg once daily for 12 weeks
Trial: 36094537
Drug: Real-time prescription
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Real-time prescription benefit recommendations
Trial: 34161745
Drug: Nitrate supplement
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate supplement (0.11 mmol nitrate/kg as beetroot juice)
Trial: 32842203
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor combined with ranitidine